HemaSphere (Jun 2022)

P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY

  • M. Gleeson,
  • C. Arias,
  • D. Cunningham,
  • C. Peckitt,
  • Y. Du,
  • N. Hujairi,
  • Y. M. To,
  • H.-C. Chen,
  • S. Patel,
  • I. Chau,
  • P. Johnson,
  • K. M. Ardeshna,
  • A. Wotherspoon,
  • A. Attygalle,
  • E. A. Hawkes,
  • M. P. Macheta,
  • G. P. Collins,
  • J. Radford,
  • A. Forbes,
  • A. Hart,
  • S. Montoto,
  • P. McKay,
  • K. Benstead,
  • N. Morley,
  • N. Kalakonda,
  • Y. Hasan,
  • D. Turner,
  • S. Chua

DOI
https://doi.org/10.1097/01.HS9.0000847612.86972.11
Journal volume & issue
Vol. 6
pp. 1073 – 1074

Abstract

Read online

No abstracts available.